# Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo

> **NCT03429595** · PHASE2 · COMPLETED · sponsor: **UNION therapeutics** · enrollment: 210 (actual)

## Conditions studied

- Impetigo

## Interventions

- **DRUG:** ATx201
- **OTHER:** ATx201 GEL Vehicle

## Key facts

- **NCT ID:** NCT03429595
- **Lead sponsor:** UNION therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-23
- **Primary completion:** 2018-06-26
- **Final completion:** 2018-06-26
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03429595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03429595, "Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03429595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*